A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants

Phase 1 Completed 52 enrolled H. Lundbeck A/S

RandomizedParallel-groupDouble-blindTreatment

Summary

The main goal of the study is to learn more about how the body absorbs and eliminates Lu AG09222 after a single dose is injected under the skin. Researchers will also investigate safety and tolerability effects of Lu AG09222 after administration.

Timeline

Start: 2022-03-18
Primary completion: 2022-10-30
Completion: 2022-10-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lu AG09222	Monoclonal antibody	—	Subcutaneous

A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants

Summary

Timeline

Drugs

Indications